Access Pharmaceuticals Provides Update on MuGard Commercial Launch... ( DALLAS Dec. 3 /- a target'

Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe

Date:12/3/2009

DALLAS, Dec. 3 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy. MuGard is commercially launched by Access' partner, SpePharm, in six European countries, including the UK, Germany, Italy, Norway, Greece and Sweden. Access is conducting pre-marketing activities, including ramping of commercial production, with the goal of a commercial launch in 1H 2010 in the US. MuGard was granted the CE mark certification in Europe in late 2008 with the labeling "prevention and management of the lesions and symptoms of oral mucositis." Key findings and feedback from SpePharm's ongoing commercial launch and patient assessment project include:

Over 15,000 bottles of MuGard have been used by over 2,000 patients since launch.
The European patient population includes adult patients undergoing radiotherapy and/or chemotherapy regimens.
Patients experience includes those being prescribed and using MuGard prophylactically, as well as those using MuGard following the onset of oral mucositis.
Initial feedback continues to reflect that MuGard is well accepted by both patients and healthcare professionals both as a preventative and curative treatment for oral mucositis.
Patients and healthcare professionals like MuGard's ready-to-use formulation, and believe it supports treatment compliance by patients.
SpePharm is currently gathering feedback from clinicians in the UK, Germany and Italy that are participating in a patient assessment project. SpePharm expects that out of a total of approximately 1,500 patients who will be given MuGard in this project, a consistent number of patient forms will be collected by year end, and th
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
2. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
3. Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
4. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
5. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
6. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
7. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
8. Access Pharmaceuticals CEO Interviewed on Financial Website
9. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
10. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
11. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 Applied Rigaku Technologies, ... that details the measurement of sulfur in ultra-low sulfur ... high resolution benchtop EDXRF analyzer . The analysis detailed ... method ISO 13032. This International Standard specifies an ... determination of sulfur content in automotive gasoline. , Regulations ...

(Date:6/19/2013)... San Diego, CA (PRWEB) June 19, 2013 ... quality pipettes, Pipette.com is now stocked with Simport’s Dropette® ... , all aimed at the customer doing basic biology, ... blood work, and serology). , For over 35 years, ... and disposable plastic labware - products like the Simport ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...

[0] Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 [0] Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] RAPS Opens Offices in Singapore and China

... A Night of Music & Comedy to Help Push Campaign to Victory May 14, 2008 ... Highline Ballroom, Spring ... ... Policy Project (MPP.org),will host a spring soiree, a night of comedy and music to benefit ...

... 13 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation ... agreement establishing a joint venture company,capable of ... May 9, General Manager of Shijiazhuang Huaxing ... and his associates visited Kiwa,s,headquarters in Beijing ...

... May 13 , - Regulated Information, ... on innovative treatments for vascular disease, eye disease ... the three month period ended,31 March 2008., ... commenting on,today,s announcement, said: "ThromboGenics, clinical development programs,are ...

Cached Biology Technology:New York Benefit to Celebrate Recent Medical Marijuana Successes 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 3 ThromboGenics N.V. - Business Update 2 ThromboGenics N.V. - Business Update 3 ThromboGenics N.V. - Business Update 4 ThromboGenics N.V. - Business Update 5 ThromboGenics N.V. - Business Update 6 ThromboGenics N.V. - Business Update 7

New York Benefit to Celebrate Recent Medical Marijuana Successes Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.ThromboGenics N.V. - Business Update

(Date:6/18/2013)... not a hacker lab. At Brandeis University, sophisticated ... are helping scientists understand the complex interplay between ... the virus, outer "shell" critical for replication. ... what we are finding will help researchers alter ... post-doctoral fellow Jason Perlmutter, first author of the ...

(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious ... 2013 ICAAC Young Investigator Award for his research on ... to infection. , Obar earned his B.A. in ... on to complete his Ph.D. in Microbiology and Immunology ... Ph.D. thesis research in Edward Usherwood,s laboratory at the ...

(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...

Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2 The American Society for Microbiology honors Joshua Obar 2 The secret of DNA methylation 2

[0] Computer modeling technique goes viral at Brandeis [0] The American Society for Microbiology honors Joshua Obar [0] The secret of DNA methylation

... being slowly stroked on the skin have their own specialised ... new study from the Sahlgrenska Academy, University of Gothenburg, Sweden. ... pain. The specialised nerve fibres in the skin are called ... in the brain that are important in the emergence of ...

... 13, 2009 -- Investigators at the Burnham Institute for ... differentiate human embryonic stem cells (hESCs) into neural progenitor ... conducted by Alexei Terskikh, Ph.D., and colleagues, outlines a ... that is replicable, does not produce mutations in the ...

... Here is the latest American Chemical Society (ACS) Weekly ... news from ACS, 34 peer-reviewed journals and Chemical & ... Chemical Society as the source for this information. ... ARTICLE # 1 FOR IMMEDIATE RELEASE, Solving the ...

Signals from stroking have direct route to brain Creating ideal neural cells for clinical use American Chemical Society Weekly PressPac -- April 8, 2009

... tabs • Reusable, press-to-seal gasket and ... assembled and disassembled for hybridizing and imaging ... thickness with up to a 13 mm ... slide. Minimize specimen handling, eliminate evaporation and ...

...

... A direct, simple approach to ... well surface of an EIA ... maintains its integrity and availability ... dry, room temperature conditions ...

AC input: 230 V...

Biology Products:

Modular hybridization system from Sigma-Aldrich LC-NMR-MSn system from Bruker Daltonics Reacti-Bind Maleic Anhydride Activated Polystyrene 96-Well plates from Pierce Biotechnology, Inc.Slide Moat Microscope Slide Incubator from Sigma-Aldrich